Common Contracts
332 similar Securities Purchase Agreement contracts by Aditxt, Inc., Evofem Biosciences, Inc., IMAC Holdings, Inc., others
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 15th, 2024 • Eastside Distilling, Inc. • Beverages • Delaware
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of November __, 2024, is by and among Eastside Distilling, Inc., a Nevada corporation with offices located at 755 Main Street, Monroe, CT 06468 (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 14th, 2024 • Kaixin Holdings • Retail-auto dealers & gasoline stations • New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of November 13, 2024, is by and among Kaixin Holdings, a company organized under the laws of the Cayman Islands with headquarters located at Unit B2-303-137, 198 Qidi Road, Beigan Community, Xiaoshan District, Hangzhou, Zhejiang Province, People’s Republic of China (the “Company”), and each of the investors listed signatory hereto (individually, a “Buyer” and collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 13th, 2024 • IMAC Holdings, Inc. • Services-specialty outpatient facilities, nec • Delaware
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of November 12, 2024, is by and among IMAC Holdings, Inc., a Delaware corporation with offices located at 3401 Mallory Lane, Suite 100, Franklin, Tennessee 37067 (the “Company”), and each of the investors signatory hereto (individually, a “Buyer” and collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 13th, 2024 • IMAC Holdings, Inc. • Services-specialty outpatient facilities, nec • Delaware
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of November 12, 2024, is by and among IMAC Holdings, Inc., a Delaware corporation with offices located at 3401 Mallory Lane, Suite 100, Franklin, Tennessee 37067 (the “Company”), and each of the investors signatory hereto (individually, a “Buyer” and collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 5th, 2024 • Nauticus Robotics, Inc. • General industrial machinery & equipment, nec • Delaware
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of November 4, 2024, is by and among Nauticus Robotics, Inc., a Delaware corporation, with offices located at 17146 Feathercraft Lane, Suite 450, Webster, TX 77598 (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 30th, 2024 • Aditxt, Inc. • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of October 28, 2024 is by and among Evofem Biosciences, Inc., a Delaware corporation with offices located at 7770 Regents Road, Suite 113-618, San Diego, CA 92122 (the “Company”), and Aditxt, Inc. (the “Buyer”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 28th, 2024 • Evofem Biosciences, Inc. • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of October 28, 2024 is by and among Evofem Biosciences, Inc., a Delaware corporation with offices located at 7770 Regents Road, Suite 113-618, San Diego, CA 92122 (the “Company”), and Aditxt, Inc. (the “Buyer”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 15th, 2024 • Microvision, Inc. • Electronic components, nec • Delaware
This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of October 14, 2024, is by and among MicroVision, Inc., a Delaware corporation with offices located at 18390 NE 68th Street, Redmond, Washington 98052 (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 8th, 2024 • Scilex Holding Co • Biological products, (no disgnostic substances) • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of October 7, 2024, is by and among Scilex Holding Company, a Delaware corporation with offices located at 960 San Antonio Road, Palo Alto, CA 94303 (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”) and Acquiom Agency Services LLC as collateral agent (the “Collateral Agent”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 3rd, 2024 • Onconetix, Inc. • Pharmaceutical preparations • Delaware
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of October 2, 2024, is by and among Onconetix, Inc., a Delaware corporation with offices located at 201 E. Fifth Street, Suite 1900 Cincinnati, OH 45202 (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 3rd, 2024 • Aditxt, Inc. • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of October 2, 2024 is by and among Evofem Biosciences, Inc., a Delaware corporation with offices located at 7770 Regents Road, Suite 113-618, San Diego, CA 92122 (the “Company”), and Aditxt, Inc. (the “Buyer”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 3rd, 2024 • Evofem Biosciences, Inc. • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of October 2, 2024 is by and among Evofem Biosciences, Inc., a Delaware corporation with offices located at 7770 Regents Road, Suite 113-618, San Diego, CA 92122 (the “Company”), and Aditxt, Inc. (the “Buyer”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 3rd, 2024 • Visionary Holdings Inc. • Services-educational services • Delaware
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of October 2, 2024, is by and among Visionary Holdings Inc. (f/k/a Visionary Education Technology Holdings Group Inc.), a company organized under the laws of Canada with offices located at 105 Moatfield Drive, Unit 1003, Toronto, Ontario, Canada M3B 0A2 (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 1st, 2024 • Aclarion, Inc. • Services-medical laboratories • Delaware
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of September 30, 2024, is by and among Aclarion, Inc., a Delaware corporation with offices located at 8181 Arista Place, Suite 100, Broomfield, CO 80021 (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND REPLACED WITH “[***]”. SUCH IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF...Securities Purchase Agreement • September 25th, 2024 • Cero Therapeutics Holdings, Inc. • Biological products, (no disgnostic substances) • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of September 25, 2024, is by and among CERo Therapeutics Holdings, Inc. a Delaware corporation with offices located at 201 Haskins Way, Suite 230, South San Francisco, CA 94080 (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 25th, 2024 • Evofem Biosciences, Inc. • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of September 20, 2024 is by and among Evofem Biosciences, Inc., a Delaware corporation with offices located at 7770 Regents Road, Suite 113-618, San Diego, CA 92122 (the “Company”), and Aditxt, Inc. (the “Buyer”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 23rd, 2024 • Aditxt, Inc. • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of September 20, 2024 is by and among Evofem Biosciences, Inc., a Delaware corporation with offices located at 7770 Regents Road, Suite 113-618, San Diego, CA 92122 (the “Company”), and Aditxt, Inc. (the “Buyer”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 30th, 2024 • Solidion Technology Inc. • Miscellaneous electrical machinery, equipment & supplies • New York
SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of [●], 2024, by and among Solidion Technology Inc., a Delaware corporation, with headquarters located at 13355 Noel Rd, Suite 1100, Dallas, Texas (the “Company”), and the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 22nd, 2024 • Noco-Noco Inc. • Miscellaneous electrical machinery, equipment & supplies • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of August 16, 2024, is by and among noco-noco, Inc. an exempted company limited by shares incorporated under the laws of the Cayman Islands (the “Company”), and the undersigned investor hereto (“Buyer”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 14th, 2024 • Evofem Biosciences, Inc. • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of August 9, 2024 is by and among Evofem Biosciences, Inc., a Delaware corporation with offices located at 7770 Regents Road, Suite 113-618, San Diego, CA 92122 (the “Company”), and Aditxt, Inc. (the “Buyer”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 13th, 2024 • Aditxt, Inc. • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of August 9, 2024 is by and among Evofem Biosciences, Inc., a Delaware corporation with offices located at 7770 Regents Road, Suite 113-618, San Diego, CA 92122 (the “Company”), and Aditxt, Inc. (the “Buyer”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 12th, 2024 • ECD Automotive Design, Inc. • Motor vehicles & passenger car bodies • Delaware
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of August 9, 2024, is by and among ECD Automotive Design, Inc. (f/k/a EF Hutton Acquisition Corporation I), a Delaware corporation with offices located at 4390 Industrial Lane, Kissimmee, FL 34758 (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 7th, 2024 • Beneficient • Finance services
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of August 6, 2024, is between BENEFICIENT, a company incorporated under the laws of the State of Nevada, with principal executive offices located at 325 North St. Paul Street, Suite 4850, Dallas, TX 75201 (the “Company”), and each of the investors listed on the Schedule of Buyers attached as Schedule I hereto (individually, a “Buyer” and collectively the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 5th, 2024 • Vocodia Holdings Corp • Services-computer programming services • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of August 2, 2024, is by and among Vocodia Holdings Corp, a Wyoming corporation with offices located at 6401 Congress Avenue, Suite #160, Boca Raton, Florida 33487 (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto and any subsequent investors party hereto pursuant to Section 1(e) (individually, a “Buyer” and collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 23rd, 2024 • Evofem Biosciences, Inc. • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of July 12, 2024 is by and among Evofem Biosciences, Inc., a Delaware corporation with offices located at 7770 Regents Road, Suite 113-618, San Diego, CA 92122 (the “Company”), and Aditxt, Inc. (the “Buyer”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 22nd, 2024 • Windtree Therapeutics Inc /De/ • Biological products, (no disgnostic substances) • Delaware
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of July 18, 2024, is by and among Windtree Therapeutics, Inc., a Delaware corporation with offices located at 2600 Kelly Road, Suite 100, Warrington, PA 18976 (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 18th, 2024 • Aditxt, Inc. • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of July 12, 2024 is by and among Evofem Biosciences, Inc., a Delaware corporation with offices located at 7770 Regents Road, Suite 113-618, San Diego, CA 92122 (the “Company”), and Aditxt, Inc. (the “Buyer”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 16th, 2024 • SCWorx Corp. • Services-miscellaneous amusement & recreation • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of July 12, 2024, is by and among SCWorx Corp., a Delaware corporation (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 24th, 2024 • Biotricity Inc. • Surgical & medical instruments & apparatus • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of June 21, 2024, is by and among Biotricity Inc., a Nevada corporation with offices located at 203 Redwood Parkway, Suite 600, Redwood City, CA 94065 (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 17th, 2024 • Xiao-I Corp • Services-prepackaged software • Delaware
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of June 17, 2024, is by and among Xiao-I Corporation, a company organized under the laws of the Cayman Islands with offices located at 5/F, Building 2, No. 2570, Hechuan Road, Minhang District, Shanghai, China 201101 (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
Securities Purchase AgreementSecurities Purchase Agreement • May 23rd, 2024 • PharmaCyte Biotech, Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (the “Agreement”), dated as of May 20, 2024, is by and among MyMD Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
Securities Purchase AgreementSecurities Purchase Agreement • May 21st, 2024 • MyMD Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • New York
This Securities Purchase Agreement (the “Agreement”), dated as of May 20, 2024, is by and among MyMD Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
Securities Purchase AgreementSecurities Purchase Agreement • May 21st, 2024 • MyMD Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • New York
This Securities Purchase Agreement (the “Agreement”), dated as of May 20, 2024, is by and among MyMD Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 14th, 2024 • Auddia Inc. • Services-computer processing & data preparation • Delaware
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of April 23, 2024, is by and among Auddia Inc., a Delaware corporation (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 8th, 2024 • Aditxt, Inc. • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of May 2, 2024, is by and among Aditxt, Inc., a Delaware corporation with offices located at 737 N. Fifth Street, Suite 200, Richmond, VA 23219 (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
